For research use only. Not for therapeutic Use.
STING Agonist-22（Cat No.:I041307）is a cutting-edge immunotherapy agent designed to activate the Stimulator of Interferon Genes (STING) pathway, a critical part of the innate immune system. By stimulating STING, the compound enhances the body’s immune response against cancer cells and viral infections. STING Agonist-22 has shown promising preclinical results in boosting anti-tumor immunity, triggering immune cell activation, and promoting the production of interferons and other cytokines. It holds significant potential for treating various cancers and viral diseases by harnessing the body’s immune system to target and eliminate abnormal cells.
| CAS Number | 2408723-12-4 |
| Synonyms | 3-[(E)-4-[5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-(3-morpholin-4-ylpropoxy)benzimidazol-1-yl]but-2-enyl]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]imidazo[4,5-b]pyridine-6-carboxamide |
| Molecular Formula | C40H48N14O6 |
| Purity | ≥95% |
| IUPAC Name | 3-[(E)-4-[5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-(3-morpholin-4-ylpropoxy)benzimidazol-1-yl]but-2-enyl]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]imidazo[4,5-b]pyridine-6-carboxamide |
| InChI | InChI=1S/C40H48N14O6/c1-5-53-30(18-24(3)48-53)37(57)46-39-44-28-20-26(34(41)55)22-32(60-15-9-10-50-13-16-59-17-14-50)33(28)51(39)11-7-8-12-52-36-29(21-27(23-43-36)35(42)56)45-40(52)47-38(58)31-19-25(4)49-54(31)6-2/h7-8,18-23H,5-6,9-17H2,1-4H3,(H2,41,55)(H2,42,56)(H,44,46,57)(H,45,47,58)/b8-7+ |
| InChIKey | HYWPJLWOHDVWMY-BQYQJAHWSA-N |
| SMILES | CCN1C(=CC(=N1)C)C(=O)NC2=NC3=C(N2C/C=C/CN4C5=C(C=C(C=N5)C(=O)N)N=C4NC(=O)C6=CC(=NN6CC)C)C(=CC(=C3)C(=O)N)OCCCN7CCOCC7 |
